Show pagesourceBacklinksCite current pageExport to PDFBack to top Share via Share via... Twitter LinkedIn Facebook Pinterest Telegram WhatsApp Yammer Reddit TeamsRecent ChangesSend via e-MailPrintPermalink × Peginterferon alfa-2a Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2AA global comparison of hepatitis B & C drug pricingHBV-specific T-cell function is nonenhanced by tenofovir-induced decline in HBV viremia or HBsAg titer in chronic hepatitis BA greater frequency of circulating CCR7loPD-1hi follicular helper T cells indicates a durable clinical cure after Peg IFN-α therapy in chronic hepatitis B patientsCytologic Diagnosis of Lymphomatoid Granulomatosis, A Case Report and Review of the LiteratureNavigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2bFrequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D InfectionA case of chronic hepatitis B who achieved clinical cure with pegylated interferon alfa intermittent and combination therapy see Peginterferon alfa-2a for cystic craniopharyngioma treatment. peginterferon_alfa-2a.txt Last modified: 2025/03/24 10:29by 127.0.0.1